Large R&D US spending powers the global flow cytometry market

In the global flow cytometry market, savvy players are expending considerable sums on building superior products such as those outfitted with infrared and ultraviolet sensors. To increase their share in the market, such players are not just adding to their product portfolios but also trying to expand geographical outreach by entering into partnerships and acquisitions. The global market for flow cytometry will likely rise at a healthy CAGR of 11.0 percent from 2017 to 2025 to reach a value of USD 8100 million by 2025, estimates Transparency Market Research.

On account of the speed and the ability of flow cytometry to examine the single-cell level, it empowers a biologist to swiftly study and characterize a multitude of cells. Mainly serving to drive demand for flow cytometry is its usage in detecting systemic ailments. Apart from that, rising instances of various chronic ailments such as cancer and immunological diseases such as AIDS or HIV, alongside hematological diseases has also pushed up demand in the market. A growing number of doctors these days prefer autologous and allergenic stem cell therapies instead of radiation and chemotherapy. This is one of the factors driving the uptake of flow cytometers. One difficulty staring at the market, on the other hand, is the emergence and soaring popularity of substitutes such as image and scanning cytometers. Limited awareness about the product is also having a negative impact.